ADDISON, Texas, Oct. 29, 2025 /PRNewswire/ — Authentix, a pioneer in Nano Optic Security Feature Technologies, today announced it has signed a Cooperation and License Agreement with LEONHARD KURZ, one of the world’s largest advanced high security feature manufacturing companies.

Authentix Inc. Signs Cooperation and License Agreement with LEONHARD KURZ Stiftung & Co. KG. to Deliver High-Volume Production of QUANTUM stripe™

This milestone confirms that QUANTUM stripe™, Authentix patented nano optic technology is now fully proven for volume manufacturing and available to the Currency market, marking a major inflection point for the industry.

Following successful technical validation for scaled manufacturing of the QUANTUM stripe nano optic feature, the partnership is focused on finalising full supply and commercial terms to meet growing global demand.

The Agreement unites Authentix breakthrough nano optic innovation with KURZ´ world-class production capacity, ensuring reliable, high-volume supply for banknote customers.

“With the manufacturing process validated and capacity secured, we are moving from innovation to full market impact,” said Alan Newman, Chief Product Officer of Authentix.
“This collaboration sets a new benchmark for the currency industry and ensures customers can access our technology at significant scale.”

The parties expect to complete definitive supply and commercial agreements soon, enabling immediate market deployment and long-term growth for this advanced cutting-edge technology.

About Authentix:  As the authority in authentication solutions, Authentix brings traceability to today’s complex global supply chains. For over 25 years, Authentix has provided clients with physical and software-enabled solutions to detect, mitigate, and prevent illicit trading activity for currency, excise taxable goods, and branded consumer products. Headquartered in Addison, Texas USA, Authentix, Inc. has offices in North America, Europe, Middle East, Asia, and Africa serving clients worldwide. For more information, visit https://www.authentix.com  Authentix® is a registered trademark of Authentix, Inc.

About LEONHARD KURZ:  KURZ Banknote Security provides the essential element to banknote security. Bringing together the ultimate combination of unique technologies, proven billions of times over on banknotes around the globe. Next to its proprietary and proven KINEGRAM® technology, KURZ produces security foils for select third parties in its dedicated, state-of-the-art Production Site in Sulzbach-Rosenberg, Germany. The KURZ Group employs over 5´500 employees in more than 30 countries and is active in a wide variety of markets. For more information about our banknote solutions, visit www.kurz-banknotes.com for more information about the KURZ Group visit www.kurz-world.com

CONSHOHOCKEN, Pa., Oct. 29, 2025 /PRNewswire/ — Suvoda (recently merged under common ownership with Greenphire), a global clinical trial technology company specializing in software solutions to address trial complexity in mission-critical, time-sensitive moments, today announced the release of its unified patient mobile app. The Suvoda app is a single, intuitive experience that will bring visit scheduling, questionnaires, travel information, receipt submission, and reimbursement tracking into one place to reduce the logistical burden for clinical trial participants.

The new patient app combines four core product capabilities in one consumer-grade interface so participants can:

• complete questionnaires and diaries
• schedule and reschedule study visits with real-time calendar availability
• view travel details and itineraries (coming early 2026)
• submit receipts and track reimbursement status
• receive automated reminders that help trials stay on track

“The Suvoda app is unlike any other participant app in the market today. It offers a unique combination of support tools that patients need. Knowing that patient dropout is a key risk to any clinical trial, our industry needs to do everything it can to support participants, so they stay enrolled in their study,” shared Jagath Wanninayake, CEO of Suvoda.

In a just-released global survey of clinical trial participants, conducted by the Center for Information and Study on Clinical Research Participation (CISCRP), researchers found that 63% of clinical trial participants said a smartphone app for data collection is a very helpful service (2025 CISCRP Perceptions and Insights Study).

Elizabeth Morris, Director of Product Management at Suvoda, agrees with those findings. “Patients consistently tell us that logistics are one of the biggest burdens of participation in a clinical trial. When people must switch between emails, phone calls, and multiple systems, it adds time and stress. Pulling everything together for patients reduces that friction and gives them one place to complete the tasks that matter.”

For patients, the app offers a simple, secure sign-in and a dashboard with assigned tasks. Clinical trial sites will be able to create automated notifications to remind patients of upcoming visits, to take their medication, or to complete questionnaires. Study teams can review and approve reimbursements in the same unified ecosystem, keeping site and participant views in sync. With these innovations, the app helps make things easier for study site teams and supports trial protocol compliance.

Following the completion of Suvoda’s merger with Greenphire earlier this year, the combined organization brings IRT, eCOA, and eConsent together with payments, travel, and budgeting capabilities—all on the Suvoda Platform, creating a comprehensive, fully integrated toolset to support the complete patient journey in clinical trials. The patient app is an example of that unified experience and will be available for download on the App Store and Google Play in the first week of November.

Additional enhancements are planned for early 2026, including adding Greenphire Travel features to the patient app and a unified Suvoda Platform login for sites and sponsors.

About Suvoda

Suvoda is a global clinical trial technology company with a real-time experience platform that empowers sponsors and CROs to make confident decisions and sites and patients to take calm, controlled action. Suvoda delivers interconnected, action-driven software solutions and industry-leading services and support, so that even in the most time-sensitive, mission-critical moments, life-changing studies keep moving forward. Headquartered outside Philadelphia, Suvoda also maintains offices in Portland, OR, Barcelona, Spain, Bucharest and Iasi, Romania, and Tokyo, Japan. The company maintains customer satisfaction scores that consistently exceed the technology industry average, contributing to the company being selected by trial sponsors and CROs to support more than 2000 trials across more than 95 countries. Suvoda recently merged with Greenphire, a leading provider of clinical trial financial management and patient support tools. To learn more, visit suvoda.com. Follow Suvoda on LinkedIn.

CONTACT:

Robin Abadía
Director, External Communications
marketing@suvoda.com

Logo – https://laotiantimes.com/wp-content/uploads/2025/10/suvoda_updated_logo.jpg 

SHANGHAI, Oct. 29, 2025 /PRNewswire/ — As AI-powered smart glasses capture market attention, Jinxin Technology Holdings’ brand Namibox (Nasdaq: NAMI) will introduce the world’s first AI-enabled smart learning glasses this December. Stay tuned for the official launch!

Designed for young users, this new wearable device stands out with its core advantages of “lightweight and stylish design, multi-color visual technology, and an integrated learning ecosystem,” offering a distinct choice in the crowded smart glasses space. 

Lightweight and Stylish Design for Diverse Lifestyles

Unlike traditional smart glasses, which are often bulky and monotonous in style, Namibox’s AI smart learning glasses seamlessly blend portability and aesthetics, overcoming what the AR industry calls the “impossible triangle” of weight, computing power, and battery life. Weighing just 35 grams—10–20% lighter than other popular models—the glasses are comfortable for extended wear, whether during a commute, studying in a library, or receiving learning reminders outdoors. With sleek, minimalist lines, they suit both low-profile academic settings and casual fashion, effortlessly bridging the gap between learning tool and trendy accessory. 

Multi-Color Visual Technology for a Personal Mobile Theater

Equipped with an industry-first MINI AR display and the world’s first binocular full-color optical waveguide lenses, the glasses use diffractive waveguide technology to provide both privacy and high-definition visuals. They simulate a screen of up to 126 inches viewed from six meters away, creating a personal mobile theater perfect for watching videos, reading, or browsing content in any posture. The glasses also support real-time photo previews and first-person content creation via simple touch controls. Removable and customizable, the lenses adapt to various scenarios without obstructing the wearer’s field of vision, ensuring safety while on the move. 

An Integrated Learning Ecosystem for Efficient, Focused Study

Unlike general-purpose smart devices, Namibox’s glasses are built with a specialized learning ecosystem, incorporating the brand’s self-developed digital education content engine and AI model capabilities. Using geometric waveguide display technology and micro projection modules, along with smart power management algorithms, the glasses deliver clear visuals and longer battery life, supporting all-day learning. Key functions—such as real-time translation during language study, lecture recording, or AI-assisted object recognition in outdoor exploration—are easily activated via voice commands or simple touch controls, freeing users’ hands and helping them stay focused. 

The product also offers personalized content recommendations based on the cognitive characteristics of different age groups, tailoring each interaction to the user’s learning needs. 

“Today’s smart glasses market is shifting from showcasing technology to deepening practical service in specific scenarios, with education emerging as a standout area,” noted an industry analyst. Following its earlier large-screen educational products for parent-child learning, Namibox’s latest glasses represent another strategic step toward building a borderless learning ecosystem.This device—lighter than some and more colorful than others—may bring fresh energy to the edtech market, bringing the vision of “learning at a glance” to life.

About Jinxin Technology Holding Company

Jinxin is an innovative digital content service provider in China, with sustainable long-term growth. Leveraging our powerful digital content generation engine powered by advanced AI/AR/VR/digital human technologies, we are committed to offering our users high-quality digital content services through both our own platform and the content distribution channels of our strong partners.

For more information, please visit: https://ir.namibox.com/index/.

Safe Harbor Statement

This announcement contains forward-looking statements. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “confident,” “potential,” “continue,” or other similar expressions. Jinxin may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission, in its annual reports to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or employees to third parties. Statements that are not historical facts, including but not limited to statements about Jinxin’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to the following: Jinxin’s goals and strategies; Jinxin’s future business development, financial conditions, and results of operations; the expected outlook of the on-demand e-commerce market in China; Jinxin’s expectations regarding demand for and market acceptance of its products and services; Jinxin’s expectations regarding its relationships with its users, clients, business partners, and other stakeholders; competition in Jinxin’s industry; Jinxin’s proposed use of proceeds; and relevant government policies and regulations relating to Jinxin’s industry, and general economic and business conditions globally and in China and assumptions underlying or related to any of the foregoing. Further information regarding these and other risks is included in the Company’s filings with the Securities and Exchange Commission. All information provided in this announcement is as of the date of this announcement, and the Company undertakes no obligation to update such information, except as required under applicable law.

For investor and media inquiries, please contact:

Jinxin Technology Holding Company
Investor Relations Department
Email: ir@namibox.com

NEW YORK, Oct. 29, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

Ashley Mastronardi delivers the pre-market update on October 29th

• Stocks are little changed on Wednesday morning ahead of a busy day on Wall Street. The major averages posted record closes for a second straight day including the S&P 500 hitting an intraday record above 6,900.
• Investors await the latest Fed decision on interest rates set to come out at 2 PM ET. Traders are anticipating a second straight cut and Fed Chair Powell’s press conference at 2:30 PM ET.
• Big tech earnings are in full swing as five Magnificent 7 companies will release quarterly figures over the next two days. Microsoft, Alphabet, and Meta will release reports today.
• AI-writing assistant Grammarly has announced a rebrand and a name change. The company revealed that it will now go by Superhuman, uniting its different platforms under one brand.

Opening Bell
Israeli Mapped in NY celebrates the impact of Israeli innovation on New York’s economy

Closing Bell
Moody’s (NYSE: MCO) celebrates the 125th anniversary of the company’s first publication

Click here to download the NYSE TV App

• Delivers AI-optimized infrastructure, and energy-efficient computing systems, from the largest design and manufacturing facility in Silicon Valley, California
• Continued growth within the U.S., with facilities and talent distributed across America

SAN JOSE, Calif., Oct. 29, 2025 /PRNewswire/ — Super Micro Computer, Inc. (SMCI), a total IT solution provider for AI/ML, HPC, Cloud, Storage, and 5G/Edge, today announced the creation of Super Micro Federal LLC to accelerate its expansion into the federal market. The new entity will focus on delivering high-performance, energy-efficient, and solutions that are developed, constructed, validated (and manufactured) in the USA to meet the evolving needs of American government agencies.  

Systems Rack Family Shot

“Supermicro is committed to supporting the U.S. federal government in powering its next generation of technical initiatives,” said Charles Liang, president and CEO of Supermicro. “Through this initiative, Supermicro will supply U.S. federal government agencies with full data center IT solutions that are manufactured and tested from our manufacturing facilities in Silicon Valley, California. With our Data Center Building Block Solutions^®, we can completely design and deliver the entire IT stack for a variety of data center requirements.”

For more information, please visit https://www.supermicro.com/en/

Supermicro’s organizational expansion deepens its commitment to American innovation, domestic manufacturing and supply chain. With engineering within the United States, the company ensures faster time-to-market and time-to-online for the federal government.

The new federal subsidiary will leverage Supermicro’s Data Center Building Block Solutions, enabling rapid customization and deployment of AI-ready systems. With its strong manufacturing capabilities in the U.S. deliver performance and cost-efficiency solutions to government agencies.

With its global headquarters in San Jose, California, and recent expansion in Silicon Valley, Supermicro continues to grow its presence in the United States. The company is also exploring new manufacturing facilities in the U.S. to meet increasing demands. These efforts reflect the company’s commitment to advancing American manufacturing and domestic job creation.

About Super Micro Computer, Inc.

Supermicro (NASDAQ: SMCI) is a global leader in Application-Optimized Total IT Solutions. Founded and operating in San Jose, California, Supermicro is committed to delivering first to market innovation for Enterprise, Cloud, AI, and 5G Telco/Edge IT Infrastructure. We are a Total IT Solutions provider with server, AI, storage, IoT, switch systems, software, and support services. Supermicro’s motherboard, power, and chassis design expertise further enables our development and production, enabling next generation innovation from cloud to edge for our global customers. Our products are designed and manufactured in-house (in the US, Asia, and the Netherlands), leveraging global operations for scale and efficiency and optimized to improve TCO and reduce environmental impact (Green Computing). The award-winning portfolio of Server Building Block Solutions® allows customers to optimize for their exact workload and application by selecting from a broad family of systems built from our flexible and reusable building blocks that support a comprehensive set of form factors, processors, memory, GPUs, storage, networking, power, and cooling solutions (air-conditioned, free air cooling or liquid cooling).

Supermicro, Server Building Block Solutions, and We Keep IT Green are trademarks and/or registered trademarks of Super Micro Computer, Inc.

All other brands, names, and trademarks are the property of their respective owners.

TAIPEI, Oct. 29, 2025 /PRNewswire/ — ARBOR Technology Corp., a global leader in industrial IoT and edge AI computing solutions, together with Datature, an innovator in no-code Vision AI platforms, and MemryX, a pioneer in AI accelerator chips, jointly announce a strategic alliance aimed at accelerating the deployment of intelligent, scalable, and integrated Vision AI solutions. This collaboration brings together complementary expertise to empower industrial applications across transportation, healthcare, manufacturing, energy, and smart cities.

Under the collaborative partnership, ARBOR’s rugged edge computing platforms will be integrated with Datature’s intuitive Vision AI software suite and powered by MemryX’s efficient AI accelerator chips. This synergy enables enterprises to rapidly annotate datasets, train custom computer vision models, and deploy them seamlessly on ARBOR’s edge devices enhanced by MemryX’s high performance, low-power AI inference capabilities, all without writing a single line of code.

Stanley Li, General Manager of ARBOR Solution (ARBOR’s U.S. subsidiary), commented:

“At ARBOR Technology, we’re excited to collaborate with Datature and MemryX to bring no-code Vision AI to the edge, where real-time intelligence drives innovation. With ARBOR’s proven expertise in system integration and advanced thermal design, our rugged edge platforms are optimized to accommodate high-performance AI modules while ensuring stable, reliable operation in demanding environments. By combining Datature’s intuitive AI development platform, MemryX’s efficient AI acceleration, and ARBOR’s robust hardware and integration capability, we deliver a seamless, ready to-deploy Vision AI solution.”

Brandon Neustadter, VP of Sales, added:

“Datature is excited to partner with ARBOR to combine our no-code vision AI platform with their advanced edge hardware, enabling customers to deploy powerful computer vision solutions faster and more efficiently.”

Keith Kressin, CEO of MemryX, shared: “At MemryX, our goal is to make AI deployment simple, scalable, and efficient across any edge platform. Partnering with ARBOR and Datature brings that vision to life by combining powerful hardware, intuitive software, and efficient AI acceleration into one seamless ecosystem. Together we are enabling customers to move from idea to real-world Vision AI applications faster than ever while maintaining exceptional performance and power efficiency.”

This partnership empowers customers to build, integrate, and scale computer vision applications efficiently across industries such as smart transportation, manufacturing, healthcare, retail, and public safety.

Media Contact
Amanda Ye
Director, Global Marketing Dept.
amanda@arbor.com.tw 
https://arbor-technology.com

Peer-reviewed (in-press) study finds serum-based antibody tests align, but milk results vary—calling for improved milk-specific diagnostics to strengthen herd surveillance and profitability

CARLSBAD, Calif., Oct. 29, 2025 /PRNewswire/ — Pictor Holdings Inc. today announced new peer-reviewed data showing close agreement between commercial antibody tests when used on serum, but higher variability when used on milk—findings that highlight the need for milk-specific diagnostic standards to scale Johne’s disease surveillance.

Johne’s disease costs the U.S. dairy industry an estimated $198 million annually (Journal of Dairy Science, Rasmussen et al., 2021). The disease, caused by the bacterium Mycobacterium avium subspecies paratuberculosis (MAP), progressively damages the gut of infected cattle, reducing nutrient absorption and milk yield. It spreads primarily through contaminated feces, milk or feed.

Key Findings:

• Serum results align strongly: Two commercial antibody tests demonstrated good agreement when used on serum (κ = 0.84–0.94), showing that serum yields consistent and comparable data across kits for herd surveillance.
• Milk results show greater variability: Agreement between the different kits on milk samples was lower (κ = 0.59–0.82), reinforcing the need for purpose-built milk assays with standardized cutoff values to ensure diagnostic reliability.
• ELISA and PCR are complementary: The study reported moderate to substantial agreement between ELISA and fecal PCR results (κ = 0.43–0.74). Each method detects a distinct biomarker—ELISA detects host antibodies to MAP exposure, while PCR identifies MAP genetic material–providing complimentary insights for herd management.

Why It Matters:
Milk is a cost-effective and practical specimen type for dairy herd level surveillance, since milk sample collection is already routine. Improving the performance of milk-based antibody tests and standardizing cutoff values could make early Johne’s disease detection more consistent and scalable–without relying on more invasive or higher-cost testing methods.

“Johne’s disease remains one of the most under-recognized burdens in global dairy production. Even at subclinical levels, it quietly erodes milk yield, herd health, and producer profitability,” said Dr. John Bannantine, retired USDA-ARS Research Microbiologist. “The wider impact reaches beyond economics—this is a disease that challenges both animal welfare and, potentially, human health. Our research is focused on finding faster, more reliable ways to detect infection early, because every day of delay compounds the loss.”

“Veterinarians, dairy farmers, and dairy testing laboratories need cost-effective tests developed specifically for milk,” said Dr Jamie Platt, CEO of Pictor Holdings, Inc. “Repurposing serum-based assays is not optimal and this study underscores why milk-specific test design is needed for reliable herd monitoring.”  

Implications for the Dairy Industry:
The study’s findings support three key actions for advancing Johne’s disease control:

• Adopt milk-first surveillance strategies using assays specifically developed for milk to maintain cost and scale advantages.
• Drive industry alignment on standardized milk test cutoff values to improve result consistency and strengthen confidence in herd management decisions.
• Integrate milk antibody testing for herd screening, complemented by fecal PCR in higher-risk herds to enhance overall diagnostic accuracy.

About the Study
The paper, “A comparative study between milk- and serum-based antibody detection assays for Johne’s disease in New Zealand dairy cattle,” analyzed samples from four dairy herds in New Zealand. Researchers compared two commercial diagnostic kits on paired milk and serum samples, with a subset also tested using fecal PCR. The study was co-funded by Pictor Ltd. (a Pictor Holdings company) and Massey Ventures Ltd.

Although conducted in New Zealand’s pasture system, these findings are relevant to dairy operations across North and South America, Europe, and Australasia. Pictor’s multiplex diagnostic platform supports veterinary labs and providers with validated, off-the-shelf serum assays as examined in this study.

The abstract is now live, with the full paper set to be published soon in Tuberculosis (Elsevier). Media can request the full paper, figure pack, or interviews with co-authors and Pictor’s technical team using the contact information below.

About Pictor
Pictor is a global leader in flexible and targeted proteomics, delivering next-generation multiplex diagnostics that empower clinical labs, diagnostic manufacturers, and veterinary providers. Its patented PictArray^™ platform, PictImager^™, and AI-powered Pictorial™ software enable faster, deeper insights from a single sample—helping improve outcomes in both human and animal health.

Headquartered in Carlsbad, CA, Pictor Holdings Inc. is committed to transforming diagnostics through scalable, high-performance solutions. Learn more at www.pictordx.com.

Media Contact:
Kelly Krueger
415-235-5031
kelly.krueger@audacityhealth.com